Drugs that contain Fish Oil Triglycerides

1. Drug name - OMEGAVEN

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10350186 FRESENIUS KABI USA Treatment and prevention of liver disease associated with parenteral nutrition (PN) Nov, 2024

(2 years from now)

US9629821 FRESENIUS KABI USA Treatment and prevention of liver disease associated with parenteral nutrition (PN) Jul, 2025

(2 years from now)

US9566260 FRESENIUS KABI USA Treatment and prevention of liver disease associated with parenteral nutrition (PN) Jul, 2025

(2 years from now)

Treatment: Treatment of parenteral nutrition-associated cholestasis in patients under the age of 12; Use for patients with parenteral nutrition associated cholestasis or parenteral nutrition associated liver disease; Treatment of liver disease through nutrition for patients under the age of 12

Dosage: EMULSION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
5GM/50ML (0.1GM/ML) EMULSION;INTRAVENOUS Prescription
10GM/100ML (0.1GM/ML) EMULSION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.